- $94.42bn
- $89.91bn
- $1.94bn
China, Hong Kong stocks rise on healthcare, tech advance
Moderna, Merck fall despite positive melanoma vaccine trial results
Chinese vaccine makers jump on news of key success in cancer treatment, CanSino leads
U.S. RESEARCH ROUNDUP-Amgen, Analog Devices, Moderna
China, Hong Kong stocks rise on healthcare, tech advance
Analysis: Moderna, Merck breakthrough could usher in wave of cancer vaccines
U.S. STOCKS ON THE MOVE-ServiceNow, Zoom, US homebuilders
Moderna shares double as cancer vaccine data rekindles investor hopes (updated)
Moderna $30 bln gain implies many cancer successes
U.S. STOCKS ON THE MOVE-Marvell, Pilgrim's Pride, ServiceNow
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Instant View: Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results
Moderna short-sellers stare at record one-day loss as shares surge on vaccine data
Instant View: Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results
Biotech stocks hit record high after Moderna, Merck's melanoma vaccine trial win
Moderna doubles after skin cancer vaccine combined with Merck's Keytruda wins late-stage trial
U.S. STOCKS ON THE MOVE-Keysight, Moderna, Marvell Technology
Biotech stocks jump after Moderna, Merck's melanoma vaccine succeeds in large trial
U.S. STOCKS ON THE MOVE-Estee Lauder, Target, Analog Devices